Vigilanz Offers COVID-19 Vaccine Management Solution Free to Customers | Healthcare IT Today

VigiLanz, a clinical surveillance company, announced the launch of a new mass vaccination support software. The company is offering Vigilanz Vaccinate free to its existing customers to help frontline healthcare teams stay safe.

I had the chance to sit down with Stacy Pur, Vice President of Product Development at Vigilanz to find out more about their product and to talk through some of the unique challenges of these early vaccines.

Why Free?

“The COVID-19 issue is personal—at VigiLanz, we have had employees and family members contract COVID-19 and require medical intervention,” said David Goldsteen, VigiLanz’s CEO. “We are so grateful for the amazing care healthcare teams are delivering across the country, and we wanted to do something to help. It was important to us to offer this tool [Vigilanz Vaccinate] to current customers for free to help them and their frontline healthcare teams stay safe during this extremely challenging global pandemic. It’s the right thing to do.”

You can read more of this article on Healthcare IT Today.

Are Hospitals Ready for a Second Wave of COVID?

PSQH Editor John Palmer recently interviewed Stacy Pur, Vice President of Product Development at VigiLanz, for a Q&A on clinical surveillance, patient safety, and COVID-19. Here’s an excerpt: 

With a potential second wave of COVID-19 on the horizon for the fall, combined with the regular flu season, real-time surveillance alerts may be the key to infection prevention as well as mitigating and controlling future on-premises infections.

PSQH: If clinical surveillance is so important, why do only 29% of surveyed hospitals use it? What would improve the rate of surveillance usage?

You can read Stacy’s response, and more of the Q&A, on PSQH and HealthLeaders.

  1. PSQH: https://www.psqh.com/analysis/are-hospitals-ready-for-a-second-wave-of-covid/
  2. HealthLeaders: https://www.healthleadersmedia.com/covid-19/are-hospitals-ready-second-wave-covid

Sharp HealthCare Turns to Clinical Surveillance for Preventing Drug, Supply Shortages

The organization is staying ahead of the game by proactively monitoring its supplies needed for COVID-19 

The ongoing COVID-19 pandemic continues to present new challenges for health system leaders, many of whom are facing critical shortages of personal protective equipment (PPE), medications, and other important supplies.

At Sharp HealthCare, the integrated delivery system based in San Diego, clinical IT professionals are using VigiLanz, a clinical surveillance software, to maximize the use of the supplies they do have, with alerts that are helping healthcare workers on the front lines.

You can read more of this article on Healthcare Innovation.  

For more on VigiLanz’s COVID-19 rules and solutions, click here.

 

Safety Is a Top Priority for Hospitals, Yet Many Report Safety Gaps

By Stacy Pur, Vice President of Product Development at VigiLanz

Safety is a top priority for hospital leaders, yet many feel that their organization could make significant safety improvements. That’s according to a survey of 123 hospital chief medical officers, chief nursing officers, chief quality officers, and other C-suite leaders conducted by Sage Growth Partners, a healthcare consulting firm.

You can read more of this article on Patient Safety & Quality Healthcare.  

For more on how VigiLanz can improve patient safety, click here.

Four Ways Hospitals Use Clinical Surveillance To Improve Patient Safety

Patient safety problems, from hospital-acquired infections to medical errors, occur much too frequently. This year, 800 hospitals will incur reimbursement penalties from Medicare because of high rates of infections and patient injuries, and a recent Johns Hopkins study found that medical errors are the third leading cause of death in the U.S. after heart disease and cancer.

You can read more of this article on Health IT Outcomes.

For more on how VigiLanz can improve patient safety, click here.

NINJA Program, Supported by VigiLanz, Helps Prevent Pediatric AKI

The following is an excerpt from Pharmacy Practice News. For more information about the collaboration between VigiLanz and Cincinnati Children’s to reduce AKI, please read our press release and learn more about the solution that is functional and customizable for any hospital, regardless of EMR platform.

Dubbed NINJA, or Nephrotoxic Injury Negated by Just-in-time Action, a new solution enables real-time identification and monitoring of pediatric patients at risk for acute kidney injury (AKI) from exposure to nephrotoxic drugs.

So far, the program appears to be putting a significant dent in the problem—a greater than 40% reduction in AKI, which the authors contend has reached epidemic proportions in the nation’s hospitals.

Nephrotoxic medication exposure is one of the most common causes of AKI in children. “We know that children need nephrotoxins. These are lifesaving medications,” said Stuart L. Goldstein, MD, the director of the Center for Acute Care Nephrology at Cincinnati Children’s Hospital Medical Center and primary developer of NINJA. “But children should only get the nephrotoxic medications they need for the duration they need them.

Hospitals Say Clinical Surveillance is Top 2019 Priority, Challenge

Nearly 90% of hospitals say clinical surveillance is a top priority, but most are struggling to implement it effectively

Most hospital executives say clinical surveillance solutions, which offer real-time, actionable insights that foster more rapid patient care interventions—including those related to pharmacy surveillance, antimicrobial stewardship, infection prevention, and safety—are very important to their organizations. However, most are also struggling to utilize these solutions effectively.

You can read more of this article on Becker’s Hospital Review. This article was based on findings from a recent survey of 100 C-suite executives.

To view the full survey findings, visit: https://vigilanzcorp.com/next-step-in-value-based-care/

Value-Focused Hospitals Look Beyond EMRs For Clinical Surveillance

More hospitals are adopting clinical surveillance solutions, but those that report the highest interest and involvement in value-based care are adopting third-party solutions rather than relying solely on EMRs or in-house solutions.

Hospitals and health systems that rate quality above all other priorities are looking to third-party clinical surveillance solutions, rather than solely relying on EMRs, to drive improvements in care quality. They also say these solutions help improve patient outcomes and their bottom lines.

You can read more of this article on Health IT Outcomes. This article was based on findings from a recent survey of 100 C-suite executives.

To view the full survey findings, visit: https://vigilanzcorp.com/next-step-in-value-based-care/